![Terrie Kellmeyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Terrie Kellmeyer
Algemeen Directeur bij
ANAVEX LIFE SCIENCES CORP.
Vermogen: - $ op 31-08-2026
Profiel
Terrie Kellmeyer is currently Chief Executive Officer at Anavex Life Sciences Corp., starting in 2026.
Former positions include Senior Vice President-Regulatory Affairs at Aardvark Therapeutics, Inc. from 2025 to 2026, Group Vice President-Clinical Development at Acer Therapeutics, Inc., and Head-Global Regulatory Affairs at Madrigal Pharmaceuticals, Inc. Education includes an undergraduate degree from Rochester Institute of Technology and a doctorate from The State University of New York.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-07-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
Actieve functies van Terrie Kellmeyer
| Bedrijven | Functie | Begin |
|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Algemeen Directeur | 04-05-2026 |
Eerdere bekende functies van Terrie Kellmeyer
| Bedrijven | Functie | Einde |
|---|---|---|
| AARDVARK THERAPEUTICS, INC. | Algemeen Adviseur | 01-05-2026 |
| ACER THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | - |
| MADRIGAL PHARMACEUTICALS, INC. | Algemeen Adviseur | - |
Opleiding van Terrie Kellmeyer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Rochester Institute of Technology
 Rochester Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The State University of New York
 The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anavex Life Sciences Corp.
 Anavex Life Sciences Corp. BiotechnologyHealth Technology Engages in the development of innovative drug compounds | Health Technology |
Madrigal Pharmaceuticals, Inc.
 Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
Aardvark Therapeutics, Inc.
 Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases | Health Technology |
